Clinical Trial

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

Study acronym: VERONICA
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of the study is to establish a de-scaling strategy of P2Y12 inhibitors (P2Y12 i) with a decrease in hemorrhagic events without increasing ischemic complications based on a Platelet Function Test (PFT).
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2020-11-29; most recent amendment 2026-01-22.
Status change: Recruiting → Active, Not Recruiting 2024-10-11
Status change: Not Yet Recruiting → Recruiting 2021-06-27
Trial Details
NCT Number NCT04654052
Lead Sponsor Fundación EPIC
Conditions Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
Enrollment 634 participants
Start Date 2021-07-02
Primary Completion 2026-12-03 (estimated)
Study Completion 2026-12-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-23